Baptist Cancer Services offers patients participation in clinical trials. Following are the clinical trials currently available as of December 2012. For more information, contact our Baptist Cancer Services Navigator, Tonya Ball, at 601-974-6238.
Genentech Aphinity– double-blind, placebo comparison of chemotherapy + Herceptin + Placebo vs. Chemotherapy + Herceptin + Pertuzumab in patients with operable HER2 positive breast cancer
Pertuzumab/Placebo is provided
Evaluation of Oncotype DX assay in Stage 3 colon cancer in determining chemotherapy
Randomized Study of Idelalisib with Rituxan and Treanda for previously treated indolent non-hodgkins lymphoma
Celgene– phase 3 randomized, double-blind study to compare efficacy and safety of Oral Azacitidine versus placebo plus best supportive care in subjects with RBC transfusion dependent anemia and thrombocytopenia due to IPSS lower risk MDS
Protocol #1200.45 - Expanded access protocol of afatinib for patients with NSCLC harboring EGFR mutation; Afatinib is provided.
Sanofi –Open label study comparing Cabazitaxel at 20 mg/m2 and 25 mg/m2 for treatment of metastatic HRPC previously treated with taxotere;
Cabazitaxel is provided by study
What can we help you find?
